Inhibitors of CYP51 As Antifungal Agents and Resistance to Azole Antifungals

作者: Steven L. Kelly , David C. Lamb , Diane E. Kelly

DOI: 10.1007/978-1-4615-4855-3_11

关键词: SterolAzoleCandida albicansCytochromeCytochrome P450FungicideMetabolic pathwayBiochemistryErgosterolChemistry

摘要: Sterol biosynthesis is an essential metabolic pathway in animals (cholesterol), fungi (ergosterol) and plants (sitosterol) (Figure 1) requires the removal of C32-methyl group at position 14α- from precursor sterols. This reaction catalysed by a microsomal cytochrome P450, sterol 14α-demethylase (cytochrome P45051, CYP51) only P450 family found so far plants, animals. Fungal CYP51 target commercially important azole drugs fungicides, which are central to therapy (>$2bn pa) represent about one-third agrochemical fungicides used ($lbn pa). The importance compounds clinic stems emergency fungal infections, but many have also developed resistance cross-resistance agents available.

参考文章(55)
Y Aoyama, Y Yoshida, S Hata, T Nishino, H Katsuki, U S Maitra, V P Mohan, D B Sprinson, Altered cytochrome P-450 in a yeast mutant blocked in demethylating C-32 of lanosterol. Journal of Biological Chemistry. ,vol. 258, pp. 9040- 9042 ,(1983) , 10.1016/S0021-9258(17)44627-8
Heinrich Buchenauer, Physiological Reactions in the Inhibition of Plant Pathogenic Fungi Chemistry of Plant Protection. pp. 217- 292 ,(1990) , 10.1007/978-3-642-46674-8_5
E. Balzi, M. Wang, S. Leterme, L. Van Dyck, A. Goffeau, PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. Journal of Biological Chemistry. ,vol. 269, pp. 2206- 2214 ,(1994) , 10.1016/S0021-9258(17)42155-7
K Venkateswarlu, D W Denning, N J Manning, S L Kelly, Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance. Antimicrobial Agents and Chemotherapy. ,vol. 40, pp. 2443- 2446 ,(1996) , 10.1128/AAC.40.11.2443
S.L Kelly, D.C Lamb, D.E Kelly, N.J Manning, J Loeffler, H Hebart, U Schumacher, H Einsele, Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6-desaturation FEBS Letters. ,vol. 400, pp. 80- 82 ,(1997) , 10.1016/S0014-5793(96)01360-9
S.L. Kelly, D.C. Lamb, A.J. Corran, B.C. Baldwin, D.E. Kelly, Mode of Action and Resistance to Azole Antifungals Associated with the Formation of 14α-Methylergosta-8,24(28)-dien-3β,6α-diol Biochemical and Biophysical Research Communications. ,vol. 207, pp. 910- 915 ,(1995) , 10.1006/BBRC.1995.1272
Mary E. Fling, Jan Kopf, Aviva Tamarkin, Jessica A. Gorman, Herbert A. Smith, Yigal Koltin, Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Molecular Genetics and Genomics. ,vol. 227, pp. 318- 329 ,(1991) , 10.1007/BF00259685
Steven L Kelly, David C Lamb, Diane E Kelly, Juergen Loeffler, Heremann Einsele, Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients The Lancet. ,vol. 348, pp. 1523- 1524 ,(1996) , 10.1016/S0140-6736(05)65949-1
Anne-Marie Alarco, Inga Balan, Driss Talibi, Norman Mainville, Martine Raymond, AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily Journal of Biological Chemistry. ,vol. 272, pp. 19304- 19313 ,(1997) , 10.1074/JBC.272.31.19304
P.F. Watson, M.E. Rose, S.L. Kelly, Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae. Medical Mycology. ,vol. 26, pp. 153- 162 ,(1988) , 10.1080/02681218880000231